A Phase I/II Study of TJ004309 for Advanced Solid Tumor

Clinical trial NCT04322006 · COMPLETED

Trial details

NCT number: NCT04322006
Sponsor: TJ Biopharma Co., Ltd.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Solid Tumor

Start date: 2020-05-09
Primary completion: 2025-04-30
Enrollment: 225

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.